Hudson Bay Capital Management »

Lenz Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1M 67k 46.58
2025-06-30 $654k 22k 29.31

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Netflix Call Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Advanced Micro Devices Put Option (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Strategy Cl A New Call Option (MSTR)
Robinhood Mkts Com Cl A Call Option (HOOD)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Dollar Tree Call Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics